Rob Davis, Merck CEO (The Galien Foundation)

Mer­ck sued the US to block the drug pric­ing law. Will oth­er phar­ma com­pa­nies fol­low suit?

Mer­ck may be the first com­pa­ny to sue and try to stop the In­fla­tion Re­duc­tion Act. But it al­most cer­tain­ly won’t be the on­ly one.

The law­suit like­ly aims to stop the US from pub­lish­ing the first list of drugs that would be sub­ject to pric­ing ne­go­ti­a­tion by Medicare, with Mer­ck al­leg­ing that the IRA vi­o­lates the First and Fifth Amend­ments by forc­ing the com­pa­ny to give dis­counts with­out the op­tion of walk­ing away, ac­cord­ing to the suit, which was filed Tues­day in the US Dis­trict Court for the Dis­trict of Co­lum­bia.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.